Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial.
about
Antiplatelet resistance in strokeAntiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation.The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population--an updated meta-analysis.Novel agents for anti-platelet therapy.Anti-inflammatory effects of the chinese herbal formula sini tang in myocardial infarction rats.Secondary prevention of stroke: Pleiotropic effects of optimal oral pharmacotherapy.Adjunctive loading dose of cilostazol in preventing periprocedural myocardial infarction.Aspirin resistance in patients with acute ischemic stroke.
P2860
Q22305927-69C8329D-50A8-41A9-A245-FC72AA12324CQ33740815-3AF5D2C5-7803-40F6-831F-2DD28D07F499Q34995043-E33F1BA9-06A6-4608-8DF4-A5065AD26BDBQ35574825-72BB092D-3227-4322-ACBA-65C2F9E3D03DQ37598541-B58975CB-E541-45E5-9D61-2DFC352F8367Q38051636-7831A3CE-F229-45EE-AE5C-34C51C00877EQ40774012-AA7966E9-BC83-4B0A-AD63-80ECA7C086C4Q51038368-F4F5D89D-C3DF-4D9C-9B6E-CDE11C36AFC7
P2860
Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Addition of cilostazol reduces ...... ind randomized clinical trial.
@en
Addition of cilostazol reduces ...... ind randomized clinical trial.
@nl
type
label
Addition of cilostazol reduces ...... ind randomized clinical trial.
@en
Addition of cilostazol reduces ...... ind randomized clinical trial.
@nl
prefLabel
Addition of cilostazol reduces ...... ind randomized clinical trial.
@en
Addition of cilostazol reduces ...... ind randomized clinical trial.
@nl
P2093
P2860
P1476
Addition of cilostazol reduces ...... ind randomized clinical trial.
@en
P2093
P2860
P304
P356
10.1111/J.1468-1331.2009.02837.X
P577
2009-11-17T00:00:00Z